Pharmafile Logo

#RemoteDetailing

- PMLiVE

EU27 backs Brexit terms – now the hard part starts for May

House of Commons looks set to oppose the deal

Medical Advisor: A new role is created at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that Dr. Beth Wynne-Evans will be taking on the role of Medical Advisor.This is a new role within Porterhouse, created to maximise the...

Porterhouse Medical Group

Comment: the new UK pricing deal – welcome news, but lessons to be learned

Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement

- PMLiVE

PMEA 2018: celebrating excellence in improving patient outcomes

Among the winners were AbbVie, Lucid Group and Takeda

- PMLiVE

Astellas makes another gene therapy play with Juventas deal

Targeting faecal incontinence, which affects 50m worldwide

Another spellbinding result for Lucid Group at the 2018 PMEAs

Lucid’s pioneering approach to medical education was clear to see as they scooped two top awards and a high commendation at last night’s awards ceremony.The first award was gained in...

Lucid Group Communications Limited

- PMLiVE

Generic threat looms to J&J’s blockbuster Zytiga in US

Impact could also be felt by Pfizer

- PMLiVE

Digital tech from Autolus and Oxford BioMedica to speed advanced therapies

UK funds efforts to make country a leader in cell and gene therapy

- PMLiVE

NICE lung cancer backing for Keytruda is biggest expansion yet

Access will be via the Cancer Drugs Fund until 2019 review

- PMLiVE

Pfizer gets first FDA nod for hedgehog inhibitor in AML

Daurismo cleared for those too frail for chemo

- PMLiVE

Five questions guiding the way to actual patient-centricity

‘91% of employees in the pharma industry believe it is very or extremely important for pharma to deliver on its patient-focused missions’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links